Header Logo

Search Results (123)

MatchTypeWhy
Recent developments in recombinant AAV-mediated gene therapy for lung diseases.Academic Article Why?
AAV-Mediated Gene Therapy for Glycosphingolipid Biosynthesis Deficiencies.Academic Article Why?
In Vivo Selection Yields AAV-B1 Capsid for Central Nervous System and Muscle Gene Therapy.Academic Article Why?
Evolution of dependoparvoviruses across geological timescales-implications for design of AAV-based gene therapy vectors.Academic Article Why?
A novel bone-targeting AAV-mediated gene therapy to promote bone formation in osteoporosisGrant Why?
Mucopolysaccharidosis-like phenotype in feline Sandhoff disease and partial correction after AAV gene therapy.Academic Article Why?
Overcoming innate immune barriers that impede AAV gene therapy vectors.Academic Article Why?
Flotte, TerencePerson Why?
AAV gene therapy for Tay-Sachs disease.Academic Article Why?
Rational engineering of a functional CpG-free ITR for AAV gene therapy.Academic Article Why?
7T MRI Predicts Amelioration of Neurodegeneration in the Brain after AAV Gene Therapy.Academic Article Why?
Intralingual and Intrapleural AAV Gene Therapy Prolongs Survival in a SOD1 ALS Mouse Model.Academic Article Why?
Lipidomic Evaluation of Feline Neurologic Disease after AAV Gene Therapy.Academic Article Why?
Wang, DanPerson Why?
Shim, Jae-HyuckPerson Why?
Per Page    Page  of 9last Nextnext
Prev
Search Criteria
  • AAV
  • Gene Therapy
Filter by Type
_
Click "Why?" to see why an item matched the search.